Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 5
Results: 27
Correction to: Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: In vitro and in vivo evaluation of anti‑tumoral effect of M1 phenotype induction in macrophages by miR‑130 and miR‑33 containing exosomes.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1475, doi. 10.1007/s00262-020-02785-4
- By:
- Publication type:
- Article
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1465, doi. 10.1007/s00262-020-02784-5
- By:
- Publication type:
- Article
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1435, doi. 10.1007/s00262-020-02781-8
- By:
- Publication type:
- Article
IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1379, doi. 10.1007/s00262-020-02778-3
- By:
- Publication type:
- Article
Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1365, doi. 10.1007/s00262-020-02776-5
- By:
- Publication type:
- Article
Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1419, doi. 10.1007/s00262-020-02775-6
- By:
- Publication type:
- Article
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1405, doi. 10.1007/s00262-020-02774-7
- By:
- Publication type:
- Article
Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1291, doi. 10.1007/s00262-020-02773-8
- By:
- Publication type:
- Article
B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1213, doi. 10.1007/s00262-020-02771-w
- By:
- Publication type:
- Article
Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1351, doi. 10.1007/s00262-020-02770-x
- By:
- Publication type:
- Article
The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1343, doi. 10.1007/s00262-020-02767-6
- By:
- Publication type:
- Article
Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1203, doi. 10.1007/s00262-020-02766-7
- By:
- Publication type:
- Article
Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1263, doi. 10.1007/s00262-020-02765-8
- By:
- Publication type:
- Article
Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1189, doi. 10.1007/s00262-020-02764-9
- By:
- Publication type:
- Article
In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1323, doi. 10.1007/s00262-020-02762-x
- By:
- Publication type:
- Article
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1255, doi. 10.1007/s00262-020-02757-8
- By:
- Publication type:
- Article
Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1177, doi. 10.1007/s00262-020-02752-z
- By:
- Publication type:
- Article
Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers – a retrospective study of a single institution.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1393, doi. 10.1007/s00262-020-02751-0
- By:
- Publication type:
- Article
Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1277, doi. 10.1007/s00262-020-02750-1
- By:
- Publication type:
- Article
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1305, doi. 10.1007/s00262-020-02749-8
- By:
- Publication type:
- Article
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1227, doi. 10.1007/s00262-020-02747-w
- By:
- Publication type:
- Article
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1451, doi. 10.1007/s00262-020-02746-x
- By:
- Publication type:
- Article
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1239, doi. 10.1007/s00262-020-02742-1
- By:
- Publication type:
- Article
Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1165, doi. 10.1007/s00262-020-02740-3
- By:
- Publication type:
- Article
Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1491, doi. 10.1007/s00262-020-02716-3
- By:
- Publication type:
- Article